Details for: MXRA7
Gene ID: 439921
Gene Type: Protein-coding - A gene that serves as a template for producing a messenger RNA (mRNA) molecule, which is then translated into a functional protein.
Symbol: MXRA7
Ensembl ID: ENSG00000182534
Description: matrix remodeling associated 7
Selected Context(s): Overall
Cell Significance Landscape
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 21.13rCSI 20.78%PRS 85.54
-
CSI 17.65rCSI 18.49%PRS 86.32
-
CSI 13.34rCSI 25.94%PRS 86.18
-
CSI 10.78rCSI 29.61%PRS 89.02
-
CSI 10.45rCSI 15.93%PRS 80.12
-
CSI 9.99rCSI 22.12%PRS 82.8
-
CSI 9.5rCSI 12.99%PRS 87.48
-
CSI 9.26rCSI 36.85%PRS 89.11
-
CSI 9.07rCSI 26.25%PRS 82.53
-
CSI 8.42rCSI 41.52%PRS 89.68
-
CSI 8.25rCSI 18.84%PRS 75.27
-
CSI 6.45rCSI 37.51%PRS 86.37
-
CSI 6.01rCSI 12.06%PRS 74.5
-
CSI 5.54rCSI 7.68%PRS 80.11
-
CSI 5.26rCSI 4.54%PRS 83.54
-
CSI 5.14rCSI 5.51%PRS 84.9
-
CSI 5.1rCSI 9%PRS 87.73
-
CSI 4.69rCSI 9.31%PRS 79.2
-
CSI 4.46rCSI 9.84%PRS 69.87
-
CSI 4.32rCSI 5.91%PRS 84.31
-
CSI 4.31rCSI 5.89%PRS 82.68
-
CSI 4.2rCSI 6.76%PRS 73.98
-
CSI 4.11rCSI 5.83%PRS 80.41
-
CSI 3.74rCSI 8.94%PRS 86.62
-
CSI 3.66rCSI 3.41%PRS 84.12
-
CSI 3.56rCSI 53.4%PRS 89.99
-
CSI 3.37rCSI 5.91%PRS 77.69
-
CSI 3.31rCSI 13.35%PRS 83.42
-
CSI 3.31rCSI 2.45%PRS 77.46
-
CSI 3.29rCSI 8.5%PRS 79.12
-
CSI 3.24rCSI 2.56%PRS 73.23
-
CSI 3.2rCSI 2.6%PRS 82.67
-
CSI 3.07rCSI 3.91%PRS 87.96
-
CSI 3.05rCSI 4.36%PRS 83.94
-
CSI 3.05rCSI 4.17%PRS 74.81
-
CSI 2.91rCSI 38.01%PRS 82.78
-
CSI 2.9rCSI 6.02%PRS 80.28
-
CSI 2.84rCSI 4.65%PRS 73.54
-
CSI 2.84rCSI 5.41%PRS 91.46
-
CSI 2.73rCSI 2.07%PRS 93.5
-
CSI 2.68rCSI 2.8%PRS 93.42
-
CSI 2.65rCSI 2.55%PRS 82.66
-
CSI 2.55rCSI 9.56%PRS 76.34
-
CSI 2.55rCSI 6.47%PRS 77.12
-
CSI 2.52rCSI 6.4%PRS 74.49
-
CSI 2.42rCSI 3.04%PRS 90.47
-
CSI 2.4rCSI 1.99%PRS 84.39
-
CSI 2.39rCSI 3.55%PRS 82.85
-
CSI 2.36rCSI 3.02%PRS 86.01
-
CSI 2.35rCSI 2.86%PRS 88.86
-
CSI 2.33rCSI 5.89%PRS 87.44
-
CSI 2.32rCSI 5.2%PRS 67.24
-
CSI 2.31rCSI 3.39%PRS 76.68
-
CSI 2.31rCSI 55.63%PRS 64.84
-
CSI 2.3rCSI 55.07%PRS 64.28
-
CSI 2.3rCSI 2.96%PRS 67.49
-
CSI 2.29rCSI 2.75%PRS 81.41
-
CSI 2.29rCSI 3.12%PRS 75.35
-
CSI 2.28rCSI 2.84%PRS 64.24
-
CSI 2.26rCSI 2.61%PRS 76.15
-
CSI 2.23rCSI 3.95%PRS 65.87
-
CSI 2.23rCSI 2.76%PRS 81.53
-
CSI 2.2rCSI 5.25%PRS 78.74
-
CSI 2.16rCSI 3.93%PRS 75.16
-
CSI 2.15rCSI 3.15%PRS 78.17
-
CSI 2.14rCSI 4.95%PRS 71.72
-
CSI 2.14rCSI 2.86%PRS 81.35
-
CSI 2.12rCSI 4.95%PRS 92.08
-
CSI 2.12rCSI 1.86%PRS 73.13
-
CSI 2.07rCSI 3.48%PRS 66.31
-
CSI 2.06rCSI 5.85%PRS 78.95
-
CSI 2.05rCSI 3.69%PRS 77.06
-
CSI 2.04rCSI 6.97%PRS 69.39
-
CSI 2.03rCSI 3.24%PRS 86.5
-
CSI 2.02rCSI 8.24%PRS 75.17
-
CSI 1.96rCSI 3.46%PRS 78.66
-
CSI 1.92rCSI 2.1%PRS 85.07
-
CSI 1.89rCSI 2.26%PRS 66.37
-
CSI 1.88rCSI 5.28%PRS 78.45
-
CSI 1.85rCSI 4.81%PRS 88.75
-
CSI 1.84rCSI 2.96%PRS 67.76
-
CSI 1.83rCSI 4.39%PRS 85.58
-
CSI 1.8rCSI 2.85%PRS 84.61
-
CSI 1.79rCSI 3.1%PRS 75.52
-
CSI 1.77rCSI 2.59%PRS 87.7
-
CSI 1.7rCSI 2.43%PRS 73.72
-
CSI 1.68rCSI 3.15%PRS 72.36
-
CSI 1.67rCSI 4.4%PRS 89
-
CSI 1.62rCSI 2.15%PRS 88.05
-
CSI 1.6rCSI 5.2%PRS 81.38
-
CSI 1.6rCSI 7.66%PRS 83.46
-
CSI 1.58rCSI 2.14%PRS 90.43
-
CSI 1.57rCSI 2.01%PRS 79.58
-
CSI 1.53rCSI 4.92%PRS 80.21
-
CSI 1.51rCSI 1.46%PRS 77.51
-
CSI 1.51rCSI 4.65%PRS 86.87
-
CSI 1.5rCSI 2.39%PRS 76.85
-
CSI 1.5rCSI 8.36%PRS 85.64
-
CSI 1.44rCSI 29.34%PRS 74.29
-
CSI 1.43rCSI 4.14%PRS 73.19
-
CSI 0.2rCSI 1.8%PRS 87.5%
-
CSI 0.2rCSI 1.3%PRS 85.4%
-
CSI 0.3rCSI 1.8%PRS 71.5%
-
CSI 0.3rCSI 1.5%PRS 93.2%
-
CSI 0.3rCSI 2.8%PRS 78.1%
-
CSI 0.5rCSI 2.7%PRS 66.9%
-
CSI 0.5rCSI 7.3%PRS 74.6%
-
CSI 0.8rCSI 15.3%PRS 89.6%
-
CSI 0.8rCSI 16.4%PRS 73.3%
-
CSI 0.9rCSI 6.2%PRS 89.9%
-
CSI 1.0rCSI 2.4%PRS 64.2%
-
CSI 1.0rCSI 3.6%PRS 64.2%
-
CSI 1.0rCSI 3.2%PRS 70.3%
-
CSI 1.1rCSI 7.7%PRS 88.6%
-
CSI 1.1rCSI 2.9%PRS 77.5%
-
CSI 1.1rCSI 3.3%PRS 87.8%
-
CSI 1.2rCSI 4.1%PRS 89.8%
-
CSI 1.3rCSI 8.1%PRS 75.7%
-
CSI 1.3rCSI 8.7%PRS 88.3%
-
CSI 1.3rCSI 1.4%PRS 86.6%
-
CSI 1.4rCSI 3.8%PRS 78.8%
-
CSI 1.4rCSI 5.2%PRS 74.8%
-
CSI 1.4rCSI 4.1%PRS 73.2%
-
CSI 1.4rCSI 29.3%PRS 74.3%
-
CSI 1.5rCSI 8.4%PRS 85.6%
-
CSI 1.5rCSI 2.4%PRS 76.9%
-
CSI 1.5rCSI 4.7%PRS 86.9%
-
CSI 1.5rCSI 1.5%PRS 77.5%
-
CSI 1.5rCSI 4.9%PRS 80.2%
-
CSI 1.6rCSI 2.0%PRS 79.6%
-
CSI 1.6rCSI 2.1%PRS 90.4%
-
CSI 1.6rCSI 7.7%PRS 83.5%
-
CSI 1.6rCSI 5.2%PRS 81.4%
-
CSI 1.6rCSI 2.2%PRS 88.1%
-
CSI 1.7rCSI 4.4%PRS 89.0%
-
CSI 1.7rCSI 3.2%PRS 72.4%
-
CSI 1.7rCSI 2.4%PRS 73.7%
-
CSI 1.8rCSI 2.6%PRS 87.7%
-
CSI 1.8rCSI 3.1%PRS 75.5%
-
CSI 1.8rCSI 2.9%PRS 84.6%
-
CSI 1.8rCSI 4.4%PRS 85.6%
-
CSI 1.8rCSI 3.0%PRS 67.8%
-
CSI 1.9rCSI 4.8%PRS 88.8%
-
CSI 1.9rCSI 5.3%PRS 78.5%
-
CSI 1.9rCSI 2.3%PRS 66.4%
-
CSI 1.9rCSI 2.1%PRS 85.1%
-
CSI 2.0rCSI 3.5%PRS 78.7%
-
CSI 2.0rCSI 8.2%PRS 75.2%
-
CSI 2.0rCSI 3.2%PRS 86.5%
-
CSI 2.0rCSI 7.0%PRS 69.4%
-
CSI 2.1rCSI 3.7%PRS 77.1%
-
CSI 2.1rCSI 5.9%PRS 79.0%
-
CSI 2.1rCSI 3.5%PRS 66.3%
-
CSI 2.1rCSI 1.9%PRS 73.1%
-
CSI 2.1rCSI 5.0%PRS 92.1%
-
CSI 2.1rCSI 2.9%PRS 81.4%
-
CSI 2.1rCSI 5.0%PRS 71.7%
-
CSI 2.2rCSI 3.2%PRS 78.2%
-
CSI 2.2rCSI 3.9%PRS 75.2%
-
CSI 2.2rCSI 5.3%PRS 78.7%
-
CSI 2.2rCSI 2.8%PRS 81.5%
-
CSI 2.2rCSI 4.0%PRS 65.9%
-
CSI 2.3rCSI 2.6%PRS 76.2%
-
CSI 2.3rCSI 2.8%PRS 64.2%
-
CSI 2.3rCSI 3.1%PRS 75.4%
-
CSI 2.3rCSI 2.8%PRS 81.4%
-
CSI 2.3rCSI 3.0%PRS 67.5%
-
CSI 2.3rCSI 55.1%PRS 64.3%
-
CSI 2.3rCSI 55.6%PRS 64.8%
-
CSI 2.3rCSI 3.4%PRS 76.7%
-
CSI 2.3rCSI 5.2%PRS 67.2%
-
CSI 2.3rCSI 5.9%PRS 87.4%
-
CSI 2.4rCSI 2.9%PRS 88.9%
-
CSI 2.4rCSI 3.0%PRS 86.0%
-
CSI 2.4rCSI 3.6%PRS 82.9%
-
CSI 2.4rCSI 2.0%PRS 84.4%
-
CSI 2.4rCSI 3.0%PRS 90.5%
-
CSI 2.5rCSI 6.4%PRS 74.5%
-
CSI 2.6rCSI 6.5%PRS 77.1%
-
CSI 2.6rCSI 9.6%PRS 76.3%
-
CSI 2.7rCSI 2.6%PRS 82.7%
-
CSI 2.7rCSI 2.8%PRS 93.4%
-
CSI 2.7rCSI 2.1%PRS 93.5%
-
CSI 2.8rCSI 5.4%PRS 91.5%
-
CSI 2.8rCSI 4.7%PRS 73.5%
-
CSI 2.9rCSI 6.0%PRS 80.3%
-
CSI 2.9rCSI 38.0%PRS 82.8%
-
CSI 3.1rCSI 4.2%PRS 74.8%
-
CSI 3.1rCSI 4.4%PRS 83.9%
-
CSI 3.1rCSI 3.9%PRS 88.0%
-
CSI 3.2rCSI 2.6%PRS 82.7%
-
CSI 3.2rCSI 2.6%PRS 73.2%
-
CSI 3.3rCSI 8.5%PRS 79.1%
-
CSI 3.3rCSI 2.5%PRS 77.5%
-
CSI 3.3rCSI 13.4%PRS 83.4%
-
CSI 3.4rCSI 5.9%PRS 77.7%
-
CSI 3.6rCSI 53.4%PRS 90.0%
-
CSI 3.7rCSI 3.4%PRS 84.1%
-
CSI 3.7rCSI 8.9%PRS 86.6%
-
CSI 4.1rCSI 5.8%PRS 80.4%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 3431253988
Symbol: MXRA7_HUMAN
Name: Matrix-remodeling-associated protein 7
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 16625196
Title: DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.
PubMed ID: 16625196
DOI: 10.1038/nature04689
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
Sequence Information:
- Length: 204
- Mass: 21466
- Checksum: 3298195FCAC7AECF
- Sequence:
MEAPAELLAA LPALATALAL LLAWLLVRRG AAASPEPARA PPEPAPPAEA TGAPAPSRPC APEPAASPAG PEEPGEPAGL GELGEPAGPG EPEGPGDPAA APAEAEEQAV EARQEEEQDL DGEKGPSSEG PEEEDGEGFS FKYSPGKLRG NQYKKMMTKE ELEEEQRVQK EQLAAIFKLM KDNKETFGEM SDGDVQEQLR LYDM
Genular Protein ID: 1916117085
Symbol: Q6ZR64_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 11237011
Title: Initial sequencing and analysis of the human genome.
PubMed ID: 11237011
DOI: 10.1038/35057062
PubMed ID: 15496913
Title: Finishing the euchromatic sequence of the human genome.
PubMed ID: 15496913
DOI: 10.1038/nature03001
PubMed ID: 16625196
Title: DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.
PubMed ID: 16625196
DOI: 10.1038/nature04689
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 19413330
Title: Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.
PubMed ID: 19413330
DOI: 10.1021/ac9004309
PubMed ID: 21269460
Title: Initial characterization of the human central proteome.
PubMed ID: 21269460
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
Sequence Information:
- Length: 213
- Mass: 23412
- Checksum: F4DC433E47378382
- Sequence:
MDTERVGDGK QHRRKQSQRL RWPCCLALVP DRHPSQLSSC TLCLLAAASQ WESWAHFSKW HTEASTGTHL GKAKAEGLGC TVKNTPQLSI CEPSHFGPSF VHSPHLLVDH DHRAGAATGR GQAGPSRASS VSPTFCPPTT SHHPVCAKGT DPVLVLQEEE QDLDGEKGPS SEGPEEEDGE GFSFKYSPGK LRGNQYKKMM TKEELEEEQR TEE